首页> 外国专利> Use of a composition comprising an estrogen and A progestin for preparing a Pharmaceutical Formulation for Contraceptive and hormone replacement therapy for Women pre menopAusica, and a kit comprising the formation of 23 to 26 Unit dose Pills.

Use of a composition comprising an estrogen and A progestin for preparing a Pharmaceutical Formulation for Contraceptive and hormone replacement therapy for Women pre menopAusica, and a kit comprising the formation of 23 to 26 Unit dose Pills.

机译:包含雌激素和孕激素的组合物在制备用于女性menopoususica的避孕和激素替代疗法的药物制剂中的用途,以及包括形成23至26个单位剂量药丸的试剂盒。

摘要

Use of a acomposicion comprising an estrogen selected 0.5 - 2,0mg of 17b - estradiol 0.008 - 0,30mg of estinilestradiol 0015 - 0060mg mestranol, and A progestin selected 0.025 0100mg levonogestrol 0010 - 0070mg of gestodene 0.025 - 0100mg of desogestrol, 0.025 0100mg - 3 - cetodesogestrol, 0.085 - 0,35mg norethindrone.For the manufacture of formula to deliver a dose of contraception and hormone replacement therapy in postmenopausal women by administration of formula of dose of 23 to 26 dThe starting on the first day of the menstrual cycle, followed by 2 to 5 White or day free pills pills for a cycle of Administration of a total of 28 days.
机译:包含雌激素的组合物的用途,所述雌激素选自0.5-2.0 mg的17b-雌二醇0.008-0.30 mg的雌甾烯醇0015-0060mg甲雌醇,以及孕激素选择的0.025 0100mg左炔诺孕酮0010-0070mg的孕二烯0.025-0100mg的去甲孕甾醇,0.025 0100 mg- 3-十六烷基孕甾醇,0.085-0.35 mg炔诺酮。用于制造可通过绝经后妇女服用避孕药和激素替代疗法的配方,剂量为23到26 d,从月经周期的第一天开始,其次是2到5粒白色或无天的药片,总共28天。

著录项

  • 公开/公告号CL1999002494A1

    专利类型

  • 公开/公告日2000-07-07

    原文格式PDF

  • 申请/专利权人 WYETH.;

    申请/专利号CL1999002494

  • 发明设计人 UPTON GERTRUDE VIRGINIA;

    申请日1999-11-02

  • 分类号A61K31/565;A61K31/567;A61K31/569;A61K31/57;A61P15/18;A61P5/24;A61P5/30;A61P5/34;

  • 国家 CL

  • 入库时间 2022-08-22 01:57:00

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号